Evidence map›Paper›PMID 29967970›Full record

ArticleMycopathologia2019

Prognostic Potential of the Panfungal Marker (1 → 3)-β-D-Glucan in Invasive Mycoses Patients.

P Pini, C Venturelli, M Girardis, F Forghieri, E Blasi

Abstract readEvaluation Study
PubMed Publisher
In one paragraph

Article in Mycopathologia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Current diagnostic approach to fungal infection in the critically ill patient.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2025
    Review
  2. Article
  3. Observational
  4. Article
  5. Biomarkers of fungal infection: Expert opinion on the current situation.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

P PiniDipartimento di Medicina Diagnostica, Clinica e di Sanità Pubblica, Istituti Biologici, Università degli Studi di Modena e Reggio Emilia, Via Campi 287, 41125, Modena, Italy.
C VenturelliAzienda Ospedaliero Universitaria-Policlinico, Modena, Italy.
M GirardisAzienda Ospedaliero Universitaria-Policlinico, Modena, Italy.
F ForghieriAzienda Ospedaliero Universitaria-Policlinico, Modena, Italy.
E BlasiDipartimento di Medicina Diagnostica, Clinica e di Sanità Pubblica, Istituti Biologici, Università degli Studi di Modena e Reggio Emilia, Via Campi 287, 41125, Modena, Italy. elisabetta.blasi@unimore.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We analyze the prognostic potential of (1 → 3)-β-D-glucan (BG) levels in predicting clinical outcomes in patients with invasive fungal infections, on a population undergoing 253 episodes (177 with positive and 76 with negative outcome). Using linear regression analysis, we assessed the prognostic potential of kinetically evaluated BG levels and we found an overall sensitivity and specificity of 68 and 82%, respectively. Moreover, using an interpretative algorithm based on two distinct cutoff values, we were able to predict the outcome in 84% of the studied population with a diagnostic accuracy of 82%.

Indexed as

beta-GlucansDiagnostic Tests, RoutineHumansInvasive Fungal InfectionsPrognosisProspective StudiesProteoglycansRetrospective StudiesSensitivity and Specificitybeta-Glucanspolysaccharide-KProteoglycansBeta glucanInvasive fungal infectionsPanfungal markerPrognostic evaluation

Identifiers

PMID29967970

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.